Windyga, J. Et Al. 2020. RURIOCTOCOG ALFA PEGOL PK-GUIDED PROPHYLAXIS TARGETING TWO FVIII TROUGH LEVELS IN SEVERE HEMOPHILIA A PATIENTS (PROPEL PHASE 3 STUDY): IMPACT OF PATIENT FVIII HALF-LIFE ON CONSUMPTION AND EFFICACY OUTCOMES. HAEMOPHILIA , vol.26 , 25.

Windyga, J., Collins, P., Escuriola-Ettingshausen, C., Escobar, M., Shapiro, S., Zulfikar, B., ... Tangada, S. D.(2020). RURIOCTOCOG ALFA PEGOL PK-GUIDED PROPHYLAXIS TARGETING TWO FVIII TROUGH LEVELS IN SEVERE HEMOPHILIA A PATIENTS (PROPEL PHASE 3 STUDY): IMPACT OF PATIENT FVIII HALF-LIFE ON CONSUMPTION AND EFFICACY OUTCOMES. HAEMOPHILIA , vol.26, 25.

Windyga, J. Et Al. "RURIOCTOCOG ALFA PEGOL PK-GUIDED PROPHYLAXIS TARGETING TWO FVIII TROUGH LEVELS IN SEVERE HEMOPHILIA A PATIENTS (PROPEL PHASE 3 STUDY): IMPACT OF PATIENT FVIII HALF-LIFE ON CONSUMPTION AND EFFICACY OUTCOMES," HAEMOPHILIA , vol.26, 25, 2020

Windyga, J. Et Al. "RURIOCTOCOG ALFA PEGOL PK-GUIDED PROPHYLAXIS TARGETING TWO FVIII TROUGH LEVELS IN SEVERE HEMOPHILIA A PATIENTS (PROPEL PHASE 3 STUDY): IMPACT OF PATIENT FVIII HALF-LIFE ON CONSUMPTION AND EFFICACY OUTCOMES." HAEMOPHILIA , vol.26, pp.25, 2020

Windyga, J. Et Al. (2020) . "RURIOCTOCOG ALFA PEGOL PK-GUIDED PROPHYLAXIS TARGETING TWO FVIII TROUGH LEVELS IN SEVERE HEMOPHILIA A PATIENTS (PROPEL PHASE 3 STUDY): IMPACT OF PATIENT FVIII HALF-LIFE ON CONSUMPTION AND EFFICACY OUTCOMES." HAEMOPHILIA , vol.26, p.25.

@article{article, author={J. Windyga Et Al. }, title={RURIOCTOCOG ALFA PEGOL PK-GUIDED PROPHYLAXIS TARGETING TWO FVIII TROUGH LEVELS IN SEVERE HEMOPHILIA A PATIENTS (PROPEL PHASE 3 STUDY): IMPACT OF PATIENT FVIII HALF-LIFE ON CONSUMPTION AND EFFICACY OUTCOMES}, journal={HAEMOPHILIA}, year=2020, pages={25} }